Hualan Biological Engineering Balance Sheet Health
Financial Health criteria checks 5/6
Hualan Biological Engineering has a total shareholder equity of CN¥13.7B and total debt of CN¥750.8M, which brings its debt-to-equity ratio to 5.5%. Its total assets and total liabilities are CN¥16.1B and CN¥2.4B respectively. Hualan Biological Engineering's EBIT is CN¥1.5B making its interest coverage ratio -9.7. It has cash and short-term investments of CN¥2.6B.
Key information
5.5%
Debt to equity ratio
CN¥750.76m
Debt
| Interest coverage ratio | -9.7x |
| Cash | CN¥2.62b |
| Equity | CN¥13.71b |
| Total liabilities | CN¥2.39b |
| Total assets | CN¥16.10b |
Recent financial health updates
Hualan Biological Engineering (SZSE:002007) Seems To Use Debt Quite Sensibly
Nov 18
These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely
Jun 07Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?
Feb 27Recent updates
Hualan Biological Engineering (SZSE:002007) Seems To Use Debt Quite Sensibly
Nov 18Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 36% Below Their Intrinsic Value Estimate
Oct 07Why Investors Shouldn't Be Surprised By Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E
Aug 22Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 26Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30
Jun 09These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely
Jun 07Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E
May 21Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?
Feb 27Financial Position Analysis
Short Term Liabilities: 002007's short term assets (CN¥9.3B) exceed its short term liabilities (CN¥2.3B).
Long Term Liabilities: 002007's short term assets (CN¥9.3B) exceed its long term liabilities (CN¥99.9M).
Debt to Equity History and Analysis
Debt Level: 002007 has more cash than its total debt.
Reducing Debt: 002007's debt to equity ratio has increased from 0% to 5.5% over the past 5 years.
Debt Coverage: 002007's debt is well covered by operating cash flow (148.2%).
Interest Coverage: 002007 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 12:11 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hualan Biological Engineering Inc. is covered by 42 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ethan Cui | BofA Global Research |
| Min Luo | Central China Securities Co., Ltd. |
| Shuchang Liu | Changjiang Securities Co. LTD. |